Nathan N. O'HAra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nathan N. O'HAra has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Gerard P. Slobogean
Department of Orthopaedic Surgery, University of California, Irvine, Irvine, CA
4 shared publications - Alex Mezei
Department of Medicine, University of British Columbia, Vancouver, BC, Canada
1 shared publication - Alexander Mezei
Faculty of Medicine, University of British Columbia, 317 - 2194 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada
1 shared publication Bababunmi K. Fashola
School of Population and Public Health, University of British Columbia, Vancouver, Canada
1 shared publication- Brad Petrisor
Division of Orthopaedic Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada
1 shared publication Bryce E Haac
School of Medicine, University of Maryland, Baltimore, Maryland, USA
1 shared publication
Latest Publications
- Open Access
- 20 April 2018
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 19 (1) , 1-7
Are large clinical trials in orthopaedic trauma justified?
The objective of this analysis is to evaluate the necessity of large clinical trials using FLOW trial data. The FLOW pilot study and definitive trial were factorial trials evaluating the effect of different irrigation solutions and pressures on re-operation. To explore treatment effects over time, we analyzed data from the pilot and definitive trial in increments of 250 patients until the final sample size of 2447 patients was reached. At each increment we calculated the relative risk (RR) and associated 95% confidence interval (CI) for the treatment effect, and compared the results that would have been reported at the smaller enrolments with those seen in the final, adequately powered study. The pilot study analysis of 89 patients and initial incremental enrolments in the FLOW definitive trial favored low pressure compared to high pressure (RR: 1.50, 95% CI: 0.75–3.04; RR: 1.39, 95% CI: 0.60–3.23, respectively), which is in contradiction to the final enrolment, which found no difference between high and low pressure (RR: 1.04, 95% CI: 0.81–1.33). In the soap versus saline comparison, the FLOW pilot study suggested that re-operation rate was similar in both the soap and saline groups (RR: 0.98, 95% CI: 0.50–1.92), whereas the FLOW definitive trial found that the re-operation rate was higher in the soap treatment arm (RR: 1.28, 95% CI: 1.04–1.57). Our findings suggest that studies with smaller sample sizes would have led to erroneous conclusions in the management of open fracture wounds. NCT01069315 (FLOW Pilot Study) Date of Registration: February 17, 2010, NCT00788398 (FLOW Definitive Trial) Date of Registration: November 10, 2008.
- 20 April 2018
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 19 (1) , 1-7
Open AccessAre large clinical trials in orthopaedic trauma justified?
The objective of this analysis is to evaluate the necessity of large clinical trials using FLOW trial data. The FLOW pilot study and definitive trial were factorial trials evaluating the effect of different irrigation solutions and pressures on re-operation. To explore treatment effects over time, we analyzed data from the pilot and definitive trial in increments of 250 patients until the final sample size of 2447 patients was reached. At each increment we calculated the relative risk (RR) and associated 95% confidence interval (CI) for the treatment effect, and compared the results that would have been reported at the smaller enrolments with those seen in the final, adequately powered study. The pilot study analysis of 89 patients and initial incremental enrolments in the FLOW definitive trial favored low pressure compared to high pressure (RR: 1.50, 95% CI: 0.75–3.04; RR: 1.39, 95% CI: 0.60–3.23, respectively), which is in contradiction to the final enrolment, which found no difference between high and low pressure (RR: 1.04, 95% CI: 0.81–1.33). In the soap versus saline comparison, the FLOW pilot study suggested that re-operation rate was similar in both the soap and saline groups (RR: 0.98, 95% CI: 0.50–1.92), whereas the FLOW definitive trial found that the re-operation rate was higher in the soap treatment arm (RR: 1.28, 95% CI: 1.04–1.57). Our findings suggest that studies with smaller sample sizes would have led to erroneous conclusions in the management of open fracture wounds. NCT01069315 (FLOW Pilot Study) Date of Registration: February 17, 2010, NCT00788398 (FLOW Definitive Trial) Date of Registration: November 10, 2008.
- Open Access
Patient preferences for nutritional supplementation to improve fracture healing: a discrete choice experiment
Objective Vitamin D is often prescribed as an adjuvant therapy to aid fracture healing due to its biological role in bone health. However, the optimal frequency, dosage and duration of vitamin D supplementation for non-osteoporotic fracture healing has not been established. The objective of this study was to determine patient preferences for fracture healing relative to hypothetical vitamin D supplementation dosing options. Design Discrete choice experiment. Setting Level 1 trauma centre in Baltimore, Maryland, USA. Participants 199 adult (18–60 years) patients with a fracture. Primary outcome measures Parameter estimates of utility for fracture healing relative to dosing regimens were analysed using hierarchical Bayesian modelling. Results A reduced risk of reoperation (34.3%) and reduced healing time (24.4%) were the attributes of greatest relative importance. The highest mean utility estimates were for a one-time supplementation dose (ß=0.71, 95% CI 0.41 to 1.00) followed by a reduced risk of reoperation (ß=0.41 per absolute % reduction, 95% CI 0.0.36 to 0.46). Supplementation for 24 weeks in duration (ß=−0.83, 95% CI −1.00 to −0.67) and a daily supplement (ß=−0.29, 95% CI −0.47 to −0.11) had the lowest mean utilities. The ‘no supplement’ option had a large negative value suggesting supplementation was generally desirable in this sample population. Among other possible clinical scenarios, patients expected a 2% reduction in the absolute risk of reoperation or a 3.1-week reduction in healing time from the baseline to accept a treatment regimen requiring two separate doses of supplementation, two blood tests and a cost of $20 within 3 months of injury. Conclusions Patients with orthopaedic trauma demonstrated strong willingness to take a vitamin D supplement that would decrease risk of reoperation and reduce healing time. Furthermore, these findings specify the required decrease in reoperation risk and reduction in healing time patients would expect to adhere to possible vitamin D dosing regimens.
Open AccessPatient preferences for nutritional supplementation to improve fracture healing: a discrete choice experiment
Objective Vitamin D is often prescribed as an adjuvant therapy to aid fracture healing due to its biological role in bone health. However, the optimal frequency, dosage and duration of vitamin D supplementation for non-osteoporotic fracture healing has not been established. The objective of this study was to determine patient preferences for fracture healing relative to hypothetical vitamin D supplementation dosing options. Design Discrete choice experiment. Setting Level 1 trauma centre in Baltimore, Maryland, USA. Participants 199 adult (18–60 years) patients with a fracture. Primary outcome measures Parameter estimates of utility for fracture healing relative to dosing regimens were analysed using hierarchical Bayesian modelling. Results A reduced risk of reoperation (34.3%) and reduced healing time (24.4%) were the attributes of greatest relative importance. The highest mean utility estimates were for a one-time supplementation dose (ß=0.71, 95% CI 0.41 to 1.00) followed by a reduced risk of reoperation (ß=0.41 per absolute % reduction, 95% CI 0.0.36 to 0.46). Supplementation for 24 weeks in duration (ß=−0.83, 95% CI −1.00 to −0.67) and a daily supplement (ß=−0.29, 95% CI −0.47 to −0.11) had the lowest mean utilities. The ‘no supplement’ option had a large negative value suggesting supplementation was generally desirable in this sample population. Among other possible clinical scenarios, patients expected a 2% reduction in the absolute risk of reoperation or a 3.1-week reduction in healing time from the baseline to accept a treatment regimen requiring two separate doses of supplementation, two blood tests and a cost of $20 within 3 months of injury. Conclusions Patients with orthopaedic trauma demonstrated strong willingness to take a vitamin D supplement that would decrease risk of reoperation and reduce healing time. Furthermore, these findings specify the required decrease in reoperation risk and reduction in healing time patients would expect to adhere to possible vitamin D dosing regimens.
- Open Access
Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment
Objective: Limited evidence for the optimal venous thromboembolism (VTE) prophylaxis regimen in orthopaedic trauma leads to variability in regimens. We sought to delineate patient preferences towards cost, complication profile, and administration route (oral tablet vs. subcutaneous injection). Design: Discrete choice experiment (DCE). Setting: Level 1 trauma center in Baltimore, USA. Participants: 232 adult trauma patients (mean age 47.9 years) with pelvic or acetabular fractures or operative extremity fractures. Primary and secondary outcome measures: Relative preferences and trade-off estimates for a 1% reduction in complications were estimated using multinomial logit modelling. Interaction terms were added to the model to assess heterogeneity in preferences. Results: Patients preferred oral tablets over subcutaneous injections (marginal utility, 0.16; 95% CI: 0.11 - 0.21, P P <0.01). Conclusions: Patients preferred oral prophylaxis and were most concerned about risk of death from PE. Furthermore, the findings estimated the trade-offs acceptable to patients and heterogeneity in preferences for VTE prophylaxis.
Open AccessPatient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment
Objective: Limited evidence for the optimal venous thromboembolism (VTE) prophylaxis regimen in orthopaedic trauma leads to variability in regimens. We sought to delineate patient preferences towards cost, complication profile, and administration route (oral tablet vs. subcutaneous injection). Design: Discrete choice experiment (DCE). Setting: Level 1 trauma center in Baltimore, USA. Participants: 232 adult trauma patients (mean age 47.9 years) with pelvic or acetabular fractures or operative extremity fractures. Primary and secondary outcome measures: Relative preferences and trade-off estimates for a 1% reduction in complications were estimated using multinomial logit modelling. Interaction terms were added to the model to assess heterogeneity in preferences. Results: Patients preferred oral tablets over subcutaneous injections (marginal utility, 0.16; 95% CI: 0.11 - 0.21, P P <0.01). Conclusions: Patients preferred oral prophylaxis and were most concerned about risk of death from PE. Furthermore, the findings estimated the trade-offs acceptable to patients and heterogeneity in preferences for VTE prophylaxis.
- 17 January 2017
- Published by Wiley in World Journal of Surgery
- Vol. 41 (6) , 1415-1419
When Surgical Resources are Severely Constrained, Who Receives Care? Determinants of Access to Orthopaedic Trauma Surgery in Uganda
Background: In low‐ and middle‐income countries, the volume of traumatic injuries requiring orthopaedic intervention routinely exceeds the capacity of available surgical resources. The objective of this study was to identify predictors of surgical care for lower extremity fracture patients at a high‐demand, resource‐limited public hospital in Uganda.Methods: Skeletally mature patients admitted with the intention of definitive surgical treatment of an isolated tibia or femur fractures to the national referral hospital in Uganda were recruited to participate in this study. Demographic, socioeconomic, and clinical data were collected through participant interviews at the time of injury and 6 months post‐injury. Social capital (use of social networks to gain access to surgery), financial leveraging, and ethnicity were also included as variables in this analysis. A probit estimation model was used to identify independent and interactive predictors of surgical treatment.Results: Of the 64 patients included in the final analysis, the majority of participants were male (83%), with a mean age of 40.6, and were injured in a motor vehicle accident (77%). Due to resource constraints, only 58% of participants received surgical care. The use of social capital and femur fractures were identified as significant predictors of receiving surgical treatment, with social capital emerging as the strongest predictor of access to surgery (p < 0.05).Conclusion: Limited infrastructure, trained personnel, and surgical supplies rations access to surgical care. In this environment, participants with advantageous social connections were able to self‐advocate for surgery where demand for these services greatly exceeded available resources.
- 17 January 2017
- Published by Wiley in World Journal of Surgery
- Vol. 41 (6) , 1415-1419
When Surgical Resources are Severely Constrained, Who Receives Care? Determinants of Access to Orthopaedic Trauma Surgery in Uganda
Background: In low‐ and middle‐income countries, the volume of traumatic injuries requiring orthopaedic intervention routinely exceeds the capacity of available surgical resources. The objective of this study was to identify predictors of surgical care for lower extremity fracture patients at a high‐demand, resource‐limited public hospital in Uganda.Methods: Skeletally mature patients admitted with the intention of definitive surgical treatment of an isolated tibia or femur fractures to the national referral hospital in Uganda were recruited to participate in this study. Demographic, socioeconomic, and clinical data were collected through participant interviews at the time of injury and 6 months post‐injury. Social capital (use of social networks to gain access to surgery), financial leveraging, and ethnicity were also included as variables in this analysis. A probit estimation model was used to identify independent and interactive predictors of surgical treatment.Results: Of the 64 patients included in the final analysis, the majority of participants were male (83%), with a mean age of 40.6, and were injured in a motor vehicle accident (77%). Due to resource constraints, only 58% of participants received surgical care. The use of social capital and femur fractures were identified as significant predictors of receiving surgical treatment, with social capital emerging as the strongest predictor of access to surgery (p < 0.05).Conclusion: Limited infrastructure, trained personnel, and surgical supplies rations access to surgical care. In this environment, participants with advantageous social connections were able to self‐advocate for surgery where demand for these services greatly exceeded available resources.
- 19 September 2016
- Published by Taylor & Francis in International Journal of Healthcare Management
- Vol. 10 (1) , 49-56
Tuberculosis testing for healthcare workers in South Africa: A health service analysis using Porter's Five Forces Framework
South Africa has one of the world's highest tuberculosis (TB) incidence rates. Healthcare workers (HCWs) are at particularly high risk of developing active TB compared to the general population, due to their occupational exposures. International guidelines support the routine screening of HCWs for active TB as an effective strategy to reduce the TB burden in high prevalence countries. However, it is estimated that only two-thirds of HCWs in South Africa will utilize available TB services at any point in their career. In this study, multiple data sources including semi-structured interviews, focus groups, observation, site visits, and secondary data analysis were synthesized and analyzed using Porter's Five Forces Framework of Competitive Position Analysis. The outcomes of this systematic evaluation found TB services available to HCWs in South Africa to be an industry with high rivalry, moderate -to -high bargaining power of the suppliers and a threat of substitutes, low bargaining power of buyers and a limited threat of new entrants. Value opportunities presented through these five forces can enhance the utilization of TB services, reducing TB-associated morbidity and mortality among this high risk, yet often neglected and under-researched population.
- 19 September 2016
- Published by Taylor & Francis in International Journal of Healthcare Management
- Vol. 10 (1) , 49-56
Tuberculosis testing for healthcare workers in South Africa: A health service analysis using Porter's Five Forces Framework
South Africa has one of the world's highest tuberculosis (TB) incidence rates. Healthcare workers (HCWs) are at particularly high risk of developing active TB compared to the general population, due to their occupational exposures. International guidelines support the routine screening of HCWs for active TB as an effective strategy to reduce the TB burden in high prevalence countries. However, it is estimated that only two-thirds of HCWs in South Africa will utilize available TB services at any point in their career. In this study, multiple data sources including semi-structured interviews, focus groups, observation, site visits, and secondary data analysis were synthesized and analyzed using Porter's Five Forces Framework of Competitive Position Analysis. The outcomes of this systematic evaluation found TB services available to HCWs in South Africa to be an industry with high rivalry, moderate -to -high bargaining power of the suppliers and a threat of substitutes, low bargaining power of buyers and a limited threat of new entrants. Value opportunities presented through these five forces can enhance the utilization of TB services, reducing TB-associated morbidity and mortality among this high risk, yet often neglected and under-researched population.